14 October 2019
Since the most recent Ebola outbreak ended in 2016, Liberia has made significant progress in the fight against the three diseases. HIV and TB services have been scaled up, and there has been notable improvement in malaria testing and treatment. The number of people on antiretroviral treatment increased by 71% between 2016 and 2018, and there have been 47% and 34% reductions in the numbers of malaria deaths and suspected malaria cases.
The Global Fund has invested heavily in improving the control environment at the Ministry of Health to strengthen its financial management capacity, and has supported work to improve the country’s supply chain. The audit however noted gaps in inventory management at the central level, and an inadequate laboratory supply chain.
Issues were also noted in relation to the contracting and oversight of sub-recipients, and in the design and implementation of interventions for Key Affected Populations. Gaps in linkages to care for HIV and MDR-TB testing and treatment are resulting in high loss to follow-up, and the private sector is not being effectively engaged to improve access to malaria services.